BlackRock Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $893K | Sell |
37,526
-843
| -2% | -$20.1K | ﹤0.01% | 1864 |
|
|
2016
Q3 | $1.41M | Sell |
38,369
-4,172
| -10% | -$153K | ﹤0.01% | 1591 |
|
|
2016
Q2 | $949K | Buy |
42,541
+98
| +0.2% | +$2.19K | ﹤0.01% | 1744 |
|
|
2016
Q1 | $883K | Buy |
42,443
+1,130
| +3% | +$23.5K | ﹤0.01% | 1761 |
|
|
2015
Q4 | $1.25M | Sell |
41,313
-5,845
| -12% | -$177K | ﹤0.01% | 1588 |
|
|
2015
Q3 | $1.17M | Buy |
47,158
+3,860
| +9% | +$95.4K | ﹤0.01% | 1570 |
|
|
2015
Q2 | $1.39M | Sell |
43,298
-11,477
| -21% | -$368K | ﹤0.01% | 1410 |
|
|
2015
Q1 | $1.96M | Buy |
54,775
+189
| +0.3% | +$6.75K | ﹤0.01% | 1216 |
|
|
2014
Q4 | $1.24M | Sell |
54,586
-48,073
| -47% | -$1.09M | ﹤0.01% | 1351 |
|
|
2014
Q3 | $1.99M | Buy |
102,659
+1,124
| +1% | +$21.8K | ﹤0.01% | 1150 |
|
|
2014
Q2 | $3.69M | Buy |
101,535
+61,368
| +153% | +$2.23M | ﹤0.01% | 1007 |
|
|
2014
Q1 | $1.56M | Buy |
40,167
+34,247
| +578% | +$1.33M | ﹤0.01% | 1262 |
|
|
2013
Q4 | $169K | Buy |
5,920
+609
| +11% | +$17.4K | ﹤0.01% | 2729 |
|
|
2013
Q3 | $190K | Buy |
5,311
+24
| +0.5% | +$859 | ﹤0.01% | 2575 |
|
|
2013
Q2 | $177K | Buy |
+5,287
| New | +$177K | ﹤0.01% | 2539 |
|